Autopsy report · NCT04021550

Improving 24-hour Blood Pressure in Obstructive Sleep Apnea

“Covid-19 Pandemic prevented this study from beginning”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Early Phase 1

Sponsor

University of British Columbia

Sponsor type

University, hospital or other

Conditions

Obstructive Sleep Apnea

Interventions

Continuous Positive Airway Pressure CPAP; Telmisartan 80mg; Alpha-Lipoic Acid 600mg; Microcrystalline Cellulose

Participants

0

Trials that died the same way

• The Efficacy of Denosumab in Incomplete Patients Spinal Cord Injury
  “Study ended early due to COVID-19” (81% match in meaning)
• Altering Mechanisms of Frailty in Persons Living With HIV Aged 50 to 65
  “COVID-19 prevented us from doing this human subjects study” (81% match in meaning)
• Pedicle Osteotomy for Stenosis Trial
  “In light of the ongoing COVID-19 pandemic and its impact on clinical trials” (80% match in meaning)
• RAman For Thyroid cancER
  “Covid19 halted study” (79% match in meaning)
• The Use of Teledermatology in the Treatment of Patients With Severe Acne on Isotretinoin
  “Study was planned prior to COVID-19; after pandemic teledermatology use became prevalent making the results of this study no longer necessary/relevant” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.